Wellnex Life Limited
Wellnex Life Limited, together with its subsidiaries, develops, markets, and sells health and wellness products in Australia, New Zealand, and the United Kingdom. The company offers topical anti-inflammatory creams, sprays, and roll-ons under the Pain Away brand; caffeine energy liquid capsules and multivitamins under the Wakey Wakey brand; sleep aid products under the Nighty Night brand; teeth w… Read more
Wellnex Life Limited (WNX) - Net Assets
Latest net assets as of June 2024: GBX3.14 Million GBX
Based on the latest financial reports, Wellnex Life Limited (WNX) has net assets worth GBX3.14 Million GBX as of June 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX30.56 Million) and total liabilities (GBX27.42 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | GBX3.14 Million |
| % of Total Assets | 10.27% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 257.41 |
Wellnex Life Limited - Net Assets Trend (2021–2024)
This chart illustrates how Wellnex Life Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Wellnex Life Limited (2021–2024)
The table below shows the annual net assets of Wellnex Life Limited from 2021 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-06-30 | GBX3.14 Million | +428.45% |
| 2023-06-30 | GBX594.00K | -86.37% |
| 2022-06-30 | GBX4.36 Million | +1850.60% |
| 2021-06-30 | GBX-249.00K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Wellnex Life Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 3296400000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | GBX134.63 Million | 1874.59% |
| Total Equity | GBX7.18 Million | 100.00% |
Wellnex Life Limited Competitors by Market Cap
The table below lists competitors of Wellnex Life Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Surgical Innovations Group plc
LSE:SUN
|
$510.74 |
|
FSTU11F
SA:FSTU11F
|
$511.26 |
|
ETAO International Co., Ltd.
PINK:ETAOF
|
$511.79 |
|
MURRAY & ROB HLDGS (LDYA.SG)
STU:LDYA
|
$511.94 |
|
Empyrean Energy Plc
LSE:EME
|
$509.41 |
|
Bay Capital PLC
LSE:BAY
|
$508.89 |
|
Vox Valor Capital Ltd.
LSE:VOX
|
$508.55 |
|
CENTRAL PETROLEUM (C9J.SG)
STU:C9J
|
$508.07 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Wellnex Life Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 594,000 to 7,182,000, a change of 6,588,000 (1109.1%).
- Net loss of 14,737,000 reduced equity.
- Share repurchases of 2,804,000 reduced equity.
- New share issuances of 20,150,000 increased equity.
- Other factors increased equity by 3,979,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | GBX-14.74 Million | -205.19% |
| Share Repurchases | GBX2.80 Million | -39.04% |
| Share Issuances | GBX20.15 Million | +280.56% |
| Other Changes | GBX3.98 Million | +55.4% |
| Total Change | GBX- | 1109.09% |
Book Value vs Market Value Analysis
This analysis compares Wellnex Life Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 37.64x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-06-30 | GBX-0.04 | GBX9.50 | x |
| 2022-06-30 | GBX0.49 | GBX9.50 | x |
| 2023-06-30 | GBX0.05 | GBX9.50 | x |
| 2024-06-30 | GBX0.25 | GBX9.50 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Wellnex Life Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -205.19%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -87.04%
- • Asset Turnover: 0.55x
- • Equity Multiplier: 4.26x
- Recent ROE (-205.19%) is above the historical average (-676.76%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | 0.00% | -2089.12% | 0.11x | 0.00x | GBX-24.94 Million |
| 2022 | -170.89% | -40.03% | 0.95x | 4.50x | GBX-7.88 Million |
| 2023 | -2330.98% | -49.67% | 1.85x | 25.32x | GBX-13.91 Million |
| 2024 | -205.19% | -87.04% | 0.55x | 4.26x | GBX-15.46 Million |
Industry Comparison
This section compares Wellnex Life Limited's net assets metrics with peer companies in the Packaged Foods industry.
Industry Context
- Industry: Packaged Foods
- Average net assets among peers: $61,492,325
- Average return on equity (ROE) among peers: -759.64%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Wellnex Life Limited (WNX) | GBX3.14 Million | 0.00% | 8.74x | $510.69 |
| Anpario Plc (ANP) | $33.15 Million | 12.07% | 0.15x | $11.75K |
| Applied Nutrition Plc (APN) | $48.02 Million | 38.84% | 0.24x | $77.41K |
| Benchmark Holdings Plc (BMK) | $279.60 Million | -4.14% | 0.72x | $16.51K |
| Carr's Group plc (CARR) | $21.37 Million | 13.66% | 1.34x | $8.72K |
| Fevara plc (FVA) | $110.09 Million | 8.75% | 0.84x | $141.81 |
| Greencore Group (GNC) | $134.90 Million | -20.93% | 5.22x | $143.86K |
| Ocean Harvest Technology Group PLC (OHT) | $5.11 Million | -66.62% | 0.08x | $153.13 |
| Premier Foods PLC (PFD) | $-18.00 Million | 0.00% | 0.00x | $202.13K |
| MicroSalt PLC (SALT) | $11.00K | -7563.64% | 11.55x | $3.48K |
| Science in Sport plc (SIS) | $674.14K | -14.42% | 3.59x | $9.38K |